Travel Time and Distance and Participation in Precision Oncology Trials at the National Cancer Center Hospital.

ABSTRACT:

Importance

Genotype-matched trials, which are becoming increasingly important in the precision oncology era, require referrals from institutions providing comprehensive genomic profiling (CGP) testing to those conducting these trials, and the travel burden for trial participation is significant. However, it remains unknown whether travel time or distance are associated with genotype-matched trial participation.

Objective

To assess whether travel time or distance are associated with disparities in genotype-matched trial participation following CGP testing.

Design, setting, and participants

This retrospective cohort study from June 2020 to June 2022 included patients with advanced or metastatic solid tumors referred to the National Cancer Center Hospital for participati

SUBMITTER: Uehara Y 

PROVIDER: S-EPMC10504617 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature